Dr. Bashey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5670 Peachtree Dunwoody Rd Ne
Suite 1000
Atlanta, GA 30342Phone+1 404-255-1930Fax+1 404-459-8510
Education & Training
- University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 1993 - 1996
- Univ Dundee- Fac MedClass of 1984
Certifications & Licensure
- CA State Medical License 1994 - 2026
- GA State Medical License 2005 - 2025
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Atlanta Magazine: Top Doctors Castle Connolly, 2013-2014, 2014-2022
Clinical Trials
- Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer Start of enrollment: 2002 Dec 01
- Fludarabine-based Conditioning for Severe Aplastic Anemia (BMT CTN 0301) Start of enrollment: 2006 Jan 01
- Combination 5-azacitidine and Gemtuzumab Ozogamicin Therapy for Treatment of Relapsed Acute Myeloid Leukemia (AML) Start of enrollment: 2005 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 256 citationsImpact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual DiseaseChristopher S. Hourigan, Laura W. Dillon, Gege Gui, Brent R. Logan, Mingwei Fei
Journal of Clinical Oncology. 2020-04-20 - 83 citationsThe European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Ha...Stefan O Ciurea, Kai Cao, Marcelo Fernandez-Vina, Piyanuch Kongtim, Monzr Al Malki
Bone Marrow Transplantation. 2018-05-01 - 498 citationsHaploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemiaStefan O. Ciurea, Mei-Jie Zhang, Andrea Bacigalupo, Asad Bashey, Frederick R. Appelbaum
Blood. 2015-08-20
Journal Articles
- The European Society for Blood and Marrow Transplantation (EBMT) Consensus Recommendations for Donor Selection in Haploidentical Hematopoietic Cell TransplantationLeo Luznik, Karen Ballen, Asad Bashey, Hillard M Lazarus, Bipin N Savani, Rizwan Romee, Ephraim J Fuchs, Nature
Abstracts/Posters
- Allogeneic Transplantation for Myelodysplastic Syndrome in Adults over 50 Years Old Using Reduced Intensity/Non-Myeloablative Conditioning: Haploidentical Relative Ver...Asad Bashey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Graft Versus Host Disease (GVHD) after HLA-Mismatched Haploidentical Transplantation with Post-Transplant Cyclophosphamide Compared to Matched Unrelated Donor: Inciden...Asad Bashey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant after Programmed Cell Death 1 (PD-1) / Programmed Cell Death Ligand 1 (PD-L1) Blockade for Classic...Asad Bashey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Improved Survival in Patients Who Undergo Relapse of Acute Myeloid Leukemia Following Allogeneic Hematopoietic Cell Transplantation61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Improved Survival of Patients Diagnosed with Severe (Grade 3-4) Acute GVHD or Severe NIH Grade Chronic GVHD in the Current Era Compared to Historic Controls61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- The Choice of Induction Regimen Affects Post Remission Survival of Acute Myelogenous Leukemia (AML) Patients with Intermediate or Poor Risk Disease2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- Late-Breaking Abstracts SessionDecember 6th, 2016
Grant Support
- CTLA-4 Blockade In Allo Stem Cell TransplantationNational Cancer Institute2002–2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: